These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36625826)

  • 1. Twenty-Strain "Universal" mRNA Flu Vaccine Effective in Animal Studies.
    Larkin H; Larkin H
    JAMA; 2023 Jan; 329(2):114. PubMed ID: 36625826
    [No Abstract]   [Full Text] [Related]  

  • 2. An mRNA Influenza Vaccine - Could It Deliver?
    Neuzil KM
    N Engl J Med; 2023 Mar; 388(12):1139-1141. PubMed ID: 36947471
    [No Abstract]   [Full Text] [Related]  

  • 3. A universal flu vaccine.
    Kesik-Brodacka M; Plucienniczak G
    Acta Biochim Pol; 2014; 61(3):523-30. PubMed ID: 25203218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the development of universal influenza vaccines.
    Gilbert SC
    Influenza Other Respir Viruses; 2013 Sep; 7(5):750-8. PubMed ID: 22998622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 6. The influenza universe in an mRNA vaccine.
    Kelvin AA; Falzarano D
    Science; 2022 Nov; 378(6622):827-828. PubMed ID: 36423290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine.
    Schmidt A; Lapuente D
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33525620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolutionary conservation and positive selection of influenza A nucleoprotein CTL epitopes for universal vaccination.
    McGee MC; Huang W
    J Med Virol; 2022 Jun; 94(6):2578-2587. PubMed ID: 35171514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Platforms for the Development of a Universal Influenza Vaccine.
    Kumar A; Meldgaard TS; Bertholet S
    Front Immunol; 2018; 9():600. PubMed ID: 29628926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of an Adenoviral Vectored Multivalent Centralized Influenza Vaccine.
    Lingel A; Bullard BL; Weaver EA
    Sci Rep; 2017 Nov; 7(1):14912. PubMed ID: 29097763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects for universal influenza virus vaccine.
    Gerhard W; Mozdzanowska K; Zharikova D
    Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More Effective Flu Vaccines Recommended for Older Adults.
    Kuehn BM
    JAMA; 2022 Aug; 328(6):519. PubMed ID: 35943466
    [No Abstract]   [Full Text] [Related]  

  • 13. Influenza virus hemagglutinin stalk-based antibodies and vaccines.
    Krammer F; Palese P
    Curr Opin Virol; 2013 Oct; 3(5):521-30. PubMed ID: 23978327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An influenza A virus vaccine based on an M2e-modified alphavirus.
    Krishnavajhala HR; Williams J; Heidner H
    Arch Virol; 2018 Feb; 163(2):483-488. PubMed ID: 29079954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2018 Mar; 93(12):142-52. PubMed ID: 29569430
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 18. Current challenges: from the path of "original antigenic sin" towards the development of universal flu vaccines.
    Biswas A; Chakrabarti AK; Dutta S
    Int Rev Immunol; 2020; 39(1):21-36. PubMed ID: 31707873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Mar; 88(11):117-25. PubMed ID: 23544238
    [No Abstract]   [Full Text] [Related]  

  • 20. [The development of influenza virus-like particle vaccines].
    Zhang LX; Yu ZJ; Zhou JF; Shu YL
    Bing Du Xue Bao; 2011 Jul; 27(4):402-8. PubMed ID: 21874913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.